LAWRENCE MILLER

Profile

First Name

: LAWRENCE

Middle Name

:

Last Name

: MILLER

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
SEQUELLA INC
LEO EINCK, JOHN FRIEDMAN, GARY HORWITH, WILLIAM HOSKINS, ALAN KLEIN, KENNETH LYNN, PAIGE MACDONALD, DAVID MCNEELEY, RONALD I MELTZER, RONALD I. MELTZER, CAROL A NACY, CAROL A. NACY, MARK RAMPY, BRADLEY ROTTER, MARTIN M ZUG
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
GAREN BOHLIN, STEVEN BOYD, JEFFREY A. CHODAKEWITZ, DOUGLAS COLE, LARRY EDWARDS, JOHN G. FREUND, L. PATRICK GAGE, ERIC M. GORDON, STEVE GULLANS, KARL D. HANDELSMAN, GERRI HENWOOD, DAVID LUBNER, GUY MACDONALD, KEITH MAHER, MARIA STAHL, CHRISTOPHER WATT, ROBERT WEISSKOFF, NANCY J. WYSENSKI
EXECUTIVE OFFICER, DIRECTOR
DANFORTH PEWTERERS LTD
ROBERT ALLEN, FREDERICK DANFORTH, JUDITH DANFORTH, TOM FUNK, JEFF GOVONI, KEVIN HARPER, BRAM KLEPPNER, KATIE LANGROCK, BETH MORRISSEY, TIM VOLK, JUSTIN WHEATING
EXECUTIVE OFFICER, DIRECTOR
STONEMOR PARTNERS LP
JEFFREY P. BISSONETTE, HOWARD L. CARVER, ALAN FISHER, ALLEN R. FREEDMAN, PETER GRUNEBAUM, ROBERT B. HELLMAN, JR., MARTIN R. LAUTMAN, PH.D., KEN LEE, JR., WILLIAM R. SHANE, MICHAEL L. STACHE, ROBERT STACHE, NONE STONEMOR GP LLC, NONE STONEMOR OPERATING LLC, NONE STONEMOR PARTNERS L.P., GREGG A. STROM, FENTON R. TALBOTT, PAUL WAIMBERG, TIMOTHY K. YOST
EXECUTIVE OFFICER, DIRECTOR
STONEMOR OPERATING LLC
JEFFREY P. BISSONETTE, HOWARD L. CARVER, ALAN FISHER, ALLEN R. FREEDMAN, PETER GRUNEBAUM, ROBERT B. HELLMAN, JR., MARTIN R. LAUTMAN, PH.D., KEN LEE, JR., WILLIAM R. SHANE, MICHAEL L. STACHE, ROBERT STACHE, NONE STONEMOR GP LLC, NONE STONEMOR OPERATING LLC, NONE STONEMOR PARTNERS L.P., GREGG A. STROM, FENTON R. TALBOTT, PAUL WAIMBERG, TIMOTHY K. YOST
EXECUTIVE OFFICER, DIRECTOR
STONEMOR INDIANA LLC
JEFFREY P. BISSONETTE, HOWARD L. CARVER, ALAN FISHER, ALLEN R. FREEDMAN, PETER GRUNEBAUM, ROBERT B. HELLMAN, JR., MARTIN R. LAUTMAN, PH.D., KEN LEE, JR., WILLIAM R. SHANE, MICHAEL L. STACHE, ROBERT STACHE, NONE STONEMOR GP LLC, NONE STONEMOR OPERATING LLC, NONE STONEMOR PARTNERS L.P., GREGG A. STROM, FENTON R. TALBOTT, PAUL WAIMBERG, TIMOTHY K. YOST
EXECUTIVE OFFICER, DIRECTOR
PANGENX, INC.
DAVID NEAFUS, ERIC NEUMANN, DANIEL A. POSCOVER
DIRECTOR
HOLGANIX, LLC
ERIC ARNSON, BARRETT ERSEK, BARRETT A ERSEK, MICHAEL GAUSLING, GENE GODICK, GENE S GODICK, A. DONALD MCCOLLUCH, JR., A. DONALD MCCULLOCH, JR., JOHN RATLIFF
DIRECTOR
CUSTOMINK, LLC
NICK BRADEN, KEVIN CHEETHAM, MARC KATZ, TED LEONSIS, FREDERICK PERKINS, FREDRICK SCHAUFELD
EXECUTIVE OFFICER
SEQUELLA INC.
LEO EINCK, JOHN FRIEDMAN, GARY HORWITH, WILLIAM HOSKINS, ALAN KLEIN, KENNETH LYNN, PAIGE MACDONALD, DAVID MCNEELEY, RONALD I MELTZER, RONALD I. MELTZER, CAROL A NACY, CAROL A. NACY, MARK RAMPY, BRADLEY ROTTER, MARTIN M ZUG
EXECUTIVE OFFICER, DIRECTOR
MACROLIDE PHARMACEUTICALS, INC.
SUMIT AGGARWAL, FEREYDOUN FIROUZ, MARKUS GOEBEL, VIKAS GOYAL, ANJA HARMEIER, ANDREW LITTLEHALE, EDWARD MASCIOLI, ANDREW MYERS, ANDREW G. MYERS, RAJ PAREKH, RAJ B. PAREKH, PH.D., MONIQUE SCIERSING, HENRY SKINNER, MARY SZELA, CHRISTOPHER VIEHBACHER, CHRISTOPHER A. VIEHBACHER, JOSEPH ZAKRZEWSKI
EXECUTIVE OFFICER, DIRECTOR
APNIMED, INC.
JOSEPH AVELLONE, JOSEPH C. AVELLONE, FRANCOIS BEAUBIEN, RAMZI BENAMAR, GERALD CHAN, ISAAC CHENG, ISAAC C. CHENG, CHRIS DIMITROPOULOS, CHRIS C. DIMITROPOULOS, RON FARQUHAR, PAUL FONTEYNE, JAMES GALEOTA, ROSY HU, RUOXI HU, STEFAN LARSON, KEVIN C. LIND, LAWRENCE G. MILLER, DENNIS MOLNAR, DENNIS C. MOLNAR, MICHAEL ROGERS, GARY SENDER, BARRY WOHL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-03-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-02 
2019-08-07
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-25 
2019-01-10
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-25 
2018-08-09
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-25 
2018-07-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-25 
2017-10-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-07 
2017-03-31
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-03-21 
2016-09-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-03 
2016-09-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-03 
2016-04-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2015-04-09
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2014-10-24 
2015-02-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2014-11-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-13 
2014-10-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-26 
2013-11-18
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-07 
2013-10-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-28 
2013-03-01
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-19 
2012-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-22 
2012-07-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-29 
2012-07-17
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-29 
2011-11-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-19 
2011-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-01 
2011-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-05-13 
2010-06-29
D
Link
OTHER 
SERVICES-PERSONAL SERVICES [7200] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-06-21 
2010-06-29
D
Link
OTHER 
SERVICES-PERSONAL SERVICES [7200] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-06-21 
2010-06-29
D
Link
OTHER 
SERVICES-PERSONAL SERVICES [7200] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-06-21 
2010-05-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-14 
2010-02-22
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2010-02-16 
2009-10-08
D
Link
RETAILING 
 
$1,000,001 - $5,000,000 
Equity 
2009-10-02 
2009-09-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-11 
2009-08-20
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-06 
2009-07-09
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2008-06-15